Judith Larkin
Family · Las Vegas, NVNPI 1306063193
Payments from drug & device makers
Across 156 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$509
- EMD Serono, Inc.$451
- Novartis$449
- AbbVie$295
- Amgen$252
- Biohaven Pharmaceutical Holding Company Ltd.$204
- plus $961 from 19 others
What the payments were for
- Consulting fees$1505%
- Speaking & faculty fees$140%
- Food & beverage$2,84791%
- Education$1114%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 10 | $509 |
| EMD Serono, Inc. | 16 | $451 |
| Novartis | 55 | $449 |
| AbbVie | 13 | $295 |
| Amgen | 14 | $252 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $204 |
| UCB, Inc. | 7 | $163 |
| Bayer | 3 | $149 |
| Boehringer Ingelheim | 1 | $104 |
| SK Life Science, Inc. | 3 | $70 |
| Teva Pharmaceuticals USA, Inc. | 4 | $67 |
| Mallinckrodt Hospital Products Inc. | 2 | $53 |
| Genentech USA, Inc. | 3 | $45 |
| Sunovion Pharmaceuticals Inc. | 2 | $44 |
| Banner Life Sciences, LLC | 3 | $43 |
| Neurelis, Inc. | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Acorda Therapeutics, Inc | 2 | $30 |
| Livanova USA, Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Johnson & Johnson | 1 | $16 |
| Medtronic | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,122 in reported general payments places this provider in the 85th percentile of 1,501 family providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $769 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $227 |
| Levetiracetam | 13 | $120 |
| Sumatriptan Succinate | 11 | $4 |
Paid to pharmacies, not to this prescriber.
Other family in Las Vegas
- John PhoenixLas Vegas$281K
- Hollie TylerLas Vegas$118K
- Jon FaillaLas Vegas$74K
- Alex LapasaranLas Vegas$50K
- Kelly PapeshLas Vegas$44K
- Erin WilkinsonLas Vegas$43K
- Anna Melisa Lopez-SanglayLas Vegas$42K
- Bernard BlanksLas Vegas$26K
- Hillary DursteinLas Vegas$21K
- Victoria HughesLas Vegas$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.